Beech Hill Advisors, Inc. Pfizer Inc Transaction History

Beech Hill Advisors, Inc.

$255 Million
Q3 2024

A detailed history of Beech Hill Advisors, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Beech Hill Advisors, Inc. holds 107,578 shares of PFE stock, worth $2.82 Million. This represents 1.22% of its overall portfolio holdings.

Number of Shares

107,578

Previous 102,788 4.66%

Holding current value

$2.82 Million

Previous $2.88 Million 8.24%

% of portfolio

1.22%

Previous 1.22%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	BUY	$27.7 - $31.39 $132,683 - $150,358	4,790 Added 4.66%	107,578 $3.11 Million
Q2 2024 Jul 12, 2024	SELL	$25.26 - $29.6 $83,105 - $97,384	-3,290 Reduced 3.1%	102,788 $2.88 Million
Q1 2024 Apr 12, 2024	BUY	$25.89 - $29.73 $213,747 - $245,450	8,256 Added 8.44%	106,078 $2.94 Million
Q4 2023 Jan 10, 2024	BUY	$26.13 - $33.94 $46,798 - $60,786	1,791 Added 1.87%	97,822 $2.82 Million
Q3 2023 Oct 10, 2023	BUY	$32.09 - $37.51 $257,201 - $300,642	8,015 Added 9.11%	96,031 $3.19 Million
Q2 2023 Jul 10, 2023	BUY	$36.12 - $41.79 $85,423 - $98,833	2,365 Added 2.76%	88,016 $3.23 Million
Q1 2023 Apr 14, 2023	BUY	$39.39 - $51.28 $23,830 - $31,024	605 Added 0.71%	85,651 $3.49 Million
Q4 2022 Jan 17, 2023	SELL	$41.75 - $54.5 $78,281 - $102,187	-1,875 Reduced 2.16%	85,046 $0
Q3 2022 Oct 12, 2022	SELL	$43.76 - $53.42 $12,034 - $14,690	-275 Reduced 0.32%	86,921 $3.8 Million
Q2 2022 Jul 11, 2022	SELL	$46.53 - $55.17 $126,701 - $150,227	-2,723 Reduced 3.03%	87,196 $4.57 Million
Q1 2022 Apr 19, 2022	SELL	$45.75 - $56.69 $64,278 - $79,649	-1,405 Reduced 1.54%	89,919 $4.66 Million
Q4 2021 Jan 19, 2022	BUY	$41.32 - $61.25 $9,503 - $14,087	230 Added 0.25%	91,324 $5.39 Million
Q3 2021 Oct 14, 2021	SELL	$39.25 - $50.42 $1.49 Million - $1.92 Million	-38,063 Reduced 29.47%	91,094 $3.92 Million
Q2 2021 Jul 15, 2021	SELL	$35.91 - $40.68 $434,475 - $492,187	-12,099 Reduced 8.57%	129,157 $5.06 Million
Q1 2021 Apr 19, 2021	BUY	$33.49 - $37.77 $55,459 - $62,547	1,656 Added 1.19%	141,256 $5.12 Million
Q4 2020 Jan 22, 2021	SELL	$33.47 - $42.56 $53,552 - $68,096	-1,600 Reduced 1.13%	139,600 $5.14 Million
Q3 2020 Oct 19, 2020	BUY	$31.75 - $37.25 $124,714 - $146,318	3,928 Added 2.86%	141,200 $5.18 Million
Q2 2020 Jul 17, 2020	BUY	$30.12 - $36.54 $85,089 - $103,225	2,825 Added 2.1%	137,272 $4.49 Million
Q1 2020 May 05, 2020	BUY	$27.03 - $38.62 $74,873 - $106,977	2,770 Added 2.1%	134,447 $4.39 Million
Q4 2019 Jan 17, 2020	BUY	$32.92 - $37.36 $47,404 - $53,798	1,440 Added 1.11%	131,677 $5.16 Million
Q3 2019 Oct 18, 2019	SELL	$32.49 - $42.13 $13,093 - $16,978	-403 Reduced 0.31%	130,237 $4.68 Million
Q2 2019 Jul 15, 2019	BUY	$36.98 - $41.52 $387,365 - $434,922	10,475 Added 8.72%	130,640 $5.66 Million
Q1 2019 Apr 09, 2019	SELL	$37.5 - $41.2 $79,687 - $87,550	-2,125 Reduced 1.74%	120,165 $5.1 Million
Q4 2018 Jan 14, 2019	SELL	$38.47 - $43.86 $169,268 - $192,984	-4,400 Reduced 3.47%	122,290 $5.34 Million
Q3 2018 Oct 10, 2018	BUY	$34.47 - $41.81 $43,983 - $53,349	1,276 Added 1.02%	126,690 $5.58 Million
Q2 2018 Aug 02, 2018	SELL	$32.98 - $35.16 $237,587 - $253,292	-7,204 Reduced 5.43%	125,414 $4.55 Million
Q1 2018 Apr 23, 2018	BUY	$31.91 - $37.02 $195,448 - $226,747	6,125 Added 4.84%	132,618 $4.71 Million
Q4 2017 Jan 23, 2018	BUY	$33.26 - $35.29 $27,772 - $29,467	835 Added 0.66%	126,493 $4.58 Million
Q3 2017 Oct 20, 2017	BUY	$31.0 - $34.15 $3.9 Million - $4.29 Million	125,658	125,658 $4.49 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beech Hill Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Beech Hill Advisors, Inc. with notifications on news.

Account

Beech Hill Advisors, Inc. Pfizer Inc Transaction History